Author

Dibya Ghimire

Massachusetts General Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:flow cytometry· 1 Organism:human· 1 Assay:imaging· 1 Assay:proteomics· 1

Frequent Co-Authors

Jacob E. LemieuxiD· 2 shared Amy K. BarczakiD· 1 shared Andrew Alexandrescu· 1 shared Benjamin L. Kotzen· 1 shared Brooke M. Leeman· 1 shared Chase B. Mandell· 1 shared Chloe M. HasundiD· 1 shared Eliza Passell· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Jacob E. LemieuxORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Subtype-specific differences in susceptibility to monoclonal antibodies and vaccines among contemporary RSV-A and RSV-B isolates

Paula Eillanny Silva Marinho, Dibya Ghimire, João Vitor Tsai Silva, Jamie Devlin, S Kwon, Gordon C. Adams, Patricia A. Jorquera, Jeremy Luban, Jacob E. Lemieux

The paper assesses subtype-specific neutralization resistance of RSV-A and RSV-B isolates to mAbs and vaccines, finding RSV-A more resistant and bivalent vaccines more effective.

Journal of Virology · Oct 5, 2026Peer-reviewedMicrobiology

Post-infection immune response in adults with COVID-19 with and without nirmatrelvir-ritonavir treatment and virologic rebound

Dibya Ghimire, Chloe M. Hasund, John Bianchi Colangeli, May Yee Liew, Emory Abar, Mamadou Barry, Andrew Alexandrescu, Benjamin L. Kotzen, Zahra Reynolds, Eliza Passell, Chase B. Mandell, Zoie Smith-Sparks, Karry Su, Julie Boucau, Owen T. Glover, , Jacob E. Lemieux

This study examines immune responses in adults with COVID-19 who received or did not receive nirmatrelvir-ritonavir, finding no differences in immune markers between those with and without virologic rebound.

bioRxiv · Jun 23, 2026 · PreprintImmunology